NH TherAguix Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Out of Business

  • Employees
  • 19

Employees

  • Latest Deal Type
  • Out of Business

NH TherAguix General Information

Description

Manufacturer of nanomedicine intended to improve radiation therapy benefits without modifying current clinical workflows. The company offers Phase I clinical development, a theranostic nanoparticle to enable professionals to target tumor tissues and tumor delineation using MRI, improving cancer treatment using radiotherapy.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 43 Boulevard du 11 Novembre 1918
  • 69100 Villeurbanne
  • France
Primary Industry
Drug Delivery
Other Industries
Drug Discovery
Pharmaceuticals
Corporate Office
  • 43 Boulevard du 11 Novembre 1918
  • 69100 Villeurbanne
  • France

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NH TherAguix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Out of Business 12-Mar-2026 Completed Out of Business
9. IPO 20-Apr-2022 Completed Generating Revenue
8. Later Stage VC 30-Apr-2021 Completed Generating Revenue
7. Secondary Transaction - Private 01-Apr-2019 Completed Generating Revenue
6. Early Stage VC 07-Jul-2018 Completed Generating Revenue
5. Grant 30-Oct-2017 Completed Generating Revenue
4. Seed Round 02-Aug-2017 Completed Generating Revenue
3. Accelerator/Incubator Completed Generating Revenue
2. Accelerator/Incubator 10-Mar-2017 $632K Completed Generating Revenue
1. Angel (individual) 24-Jan-2017 $632K $632K Completed Generating Revenue
To view NH TherAguix’s complete valuation and funding history, request access »

NH TherAguix Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Preference A
To view NH TherAguix’s complete cap table history, request access »

NH TherAguix Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of nanomedicine intended to improve radiation therapy benefits without modifying current clinical workflows
Drug Delivery
Villeurbanne, France
19 As of 2025

Carlsbad, CA

Fort Worth, TX
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

NH TherAguix Competitors (56)

One of NH TherAguix’s 56 competitors is Renova Therapeutics, a Venture Capital-Backed company based in Carlsbad, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Renova Therapeutics Venture Capital-Backed Carlsbad, CA
NanOlogy (Pharmaceutical) Corporate Backed or Acquired Fort Worth, TX
Cristal Therapeutics Venture Capital-Backed Maastricht, Netherlands
Peloton Therapeutics Formerly VC-backed Dallas, TX
Emmaus Life Sciences Formerly VC-backed Torrance, CA
You’re viewing 5 of 56 competitors. Get the full list »

NH TherAguix Patents

NH TherAguix Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2026527573-A Method and related apparatus for quantifying the concentration of contrast agent Pending 31-Jul-2023
FR-3151755-A1 Method for quantifying the concentration of a contrast agent and associated device Pending 31-Jul-2023
WO-2025026987-A1 Mri method for quantifying the concentration of a contrast agent and associated device Inactive 31-Jul-2023
WO-2024236048-A1 Combination therapy for treating tumors with radiotherapy Inactive 16-May-2023
US-20260232805-A1 Methods for imaging using spcct Pending 18-Oct-2022 A61K41/0038
To view NH TherAguix’s complete patent history, request access »

NH TherAguix Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NH TherAguix FAQs

  • When was NH TherAguix founded?

    NH TherAguix was founded in 2015.

  • Where is NH TherAguix headquartered?

    NH TherAguix is headquartered in Villeurbanne, France.

  • What is the size of NH TherAguix?

    NH TherAguix has 19 total employees.

  • What industry is NH TherAguix in?

    NH TherAguix’s primary industry is Drug Delivery.

  • Is NH TherAguix a private or public company?

    NH TherAguix is a Private company.

  • What is NH TherAguix’s current revenue?

    The current revenue for NH TherAguix is .

  • How much funding has NH TherAguix raised over time?

    NH TherAguix has raised $52.2M.

  • Who are NH TherAguix’s competitors?

    Renova Therapeutics, NanOlogy (Pharmaceutical), Cristal Therapeutics, Peloton Therapeutics, and Emmaus Life Sciences are some of the 56 competitors of NH TherAguix.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process